Table 1.
Baseline and study end point clinical bleeding on probing (BOP) (%) in the bilberry, placebo and standard of care reference groups. (BL = baseline, EP = study endpoint, Ch = change, SOC = standard of care).
| Individual | 250 g Bilberry | 500 g Bilberry | Placebo | SOC | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BL (%) | EP (%) | Ch (%) | BL (%) | EP (%) | Ch (%) | BL (%) | EP (%) | Ch (%) | BL (%) | EP (%) | Ch (%) | |
| 1 | 13 | 6 | 54 | 34 | 18 | 47 | 37 | 15 | 59 | 53 | 18 | 66 |
| 2 | 23 | 11 | 52 | 48 | 33 | 31 | 54 | 54 | 0 | 32 | 14 | 56 |
| 3 | 28 | 17 | 39 | 30 | 8 | 73 | 25 | 25 | 0 | 43 | 27 | 37 |
| 4 | 25 | 14 | 44 | 29 | 15 | 48 | 39 | 26 | 33 | 33 | 4 | 88 |
| 5 | 33 | 21 | 36 | 24 | 8 | 67 | 31 | 21 | 32 | 33 | 12 | 64 |
| 6 | 21 | 11 | 48 | 39 | 16 | 59 | 26 | 14 | 46 | 36 | 20 | 44 |
| 7 | 23 | 19 | 17 | 39 | 10 | 74 | 31 | 16 | 48 | 37 | 15 | 59 |
| 8 | 23 | 15 | 35 | 25 | 7 | 72 | 26 | 18 | 31 | 50 | 27 | 46 |
| mean | 25 | 15 | 41 | 34 | 14 | 59 | 34 | 24 | 31 | 40 | 17 | 58 |